Autolus Therapeutics PLC (AUTL)
4.19
+0.08
(+1.95%)
USD |
NASDAQ |
May 03, 16:00
4.185
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics 1 Year Total Returns (Daily): 113.8% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 113.8% |
| May 02, 2024 | 109.7% |
| May 01, 2024 | 115.1% |
| April 30, 2024 | 103.3% |
| April 29, 2024 | 109.9% |
| April 26, 2024 | 143.9% |
| April 25, 2024 | 135.8% |
| April 24, 2024 | 136.5% |
| April 23, 2024 | 148.9% |
| April 22, 2024 | 153.3% |
| April 19, 2024 | 144.3% |
| April 18, 2024 | 158.1% |
| April 17, 2024 | 163.0% |
| April 16, 2024 | 170.0% |
| April 15, 2024 | 172.2% |
| April 12, 2024 | 178.9% |
| April 11, 2024 | 194.5% |
| April 10, 2024 | 189.3% |
| April 09, 2024 | 198.4% |
| April 08, 2024 | 198.4% |
| April 05, 2024 | 207.7% |
| April 04, 2024 | 202.7% |
| April 03, 2024 | 183.0% |
| April 02, 2024 | 199.5% |
| April 01, 2024 | 208.7% |
| Date | Value |
|---|---|
| March 28, 2024 | 264.6% |
| March 27, 2024 | 237.3% |
| March 26, 2024 | 239.0% |
| March 25, 2024 | 247.8% |
| March 22, 2024 | 239.8% |
| March 21, 2024 | 201.9% |
| March 20, 2024 | 218.0% |
| March 19, 2024 | 196.7% |
| March 18, 2024 | 196.9% |
| March 15, 2024 | 178.5% |
| March 14, 2024 | 171.4% |
| March 13, 2024 | 171.3% |
| March 12, 2024 | 183.7% |
| March 11, 2024 | 184.7% |
| March 08, 2024 | 179.9% |
| March 07, 2024 | 180.7% |
| March 06, 2024 | 196.3% |
| March 05, 2024 | 209.8% |
| March 04, 2024 | 214.7% |
| March 01, 2024 | 231.4% |
| February 29, 2024 | 209.3% |
| February 28, 2024 | 205.7% |
| February 27, 2024 | 218.1% |
| February 26, 2024 | 240.3% |
| February 23, 2024 | 223.3% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-83.03%
Minimum
Mar 18 2020
300.5%
Maximum
Jan 11 2024
-16.25%
Average
-42.35%
Median
1 Year Total Returns (Daily) Benchmarks
| Adaptimmune Therapeutics PLC | -15.00% |
| Biodexa Pharmaceuticals Plc | -93.25% |
| NuCana PLC | -78.47% |
| TC BioPharm (Holdings) PLC | -93.42% |
| Mereo BioPharma Group PLC | 162.9% |